Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1991
Metabolism of 7-(1,3-dithiolan-2-ylmethyl)-1,3-dimethylxanthine by rat liver microsomes. Diastereoselective metabolism of the 1,3-dithiolane ringG Grosa, O Caputo, M Ceruti, et al.
Drugs Under Experimental and Clinical Research|January 1, 1988
Effect of teomorfolin [N-(7'-theophylline acetyl)morpholine], a new drug, on dislipidaemic conditions induced in the ratJ S Franzone, R Cirillo, M C Reboani, et al.
International Journal of Tissue Reactions|January 1, 1988
Biological properties of pancreatic elastase in relation to atherosclerotic diseaseJ S Franzone, C Cravanzola, M C Reboani, et al.
International Journal of Immunopathology and Pharmacology|March 14, 2008
Periodate oxidized ATP (oATP) reduces hyperalgesia in mice: involvement of P2X7 receptors and implications for therapyA Fulgenzi, P Ticozzi, C A Gabel, et al.
Farmaco (Societa Chimica Italiana : 1989)|March 1, 1989
Synthesis, antilipidemic and platelet antiaggregatory activity of 2-aminobenzimidazole amide derivativesP Caroti, C Ceccotti, F Da Settimo, et al.
Digestive Diseases and Sciences|April 12, 2000
A randomized, controlled study of thymosin-alpha1 therapy in patients with anti-HBe, HBV-DNA-positive chronic hepatitis BC Zavaglia, R Severini, C Tinelli, et al.
Il Farmaco; Edizione Scientifica|January 1, 1987
Synthesis and antiinflammatory activity of some N-(5-substituted indole-3-ylglyoxyl)amine derivativesA Da Settimo, G Primofiore, A M Marini, et al.
International Journal of Clinical Pharmacology Research|January 1, 1989
Treatment of reversible chronic airways obstruction with doxofylline compared with slow-release theophylline: a double-blind, randomized, multicentre trialG Melillo, G Balzano, F Jodice, et al.
Hepatology (Baltimore, Md.)|October 1, 1996
A randomized controlled trial of thymosin-alpha1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody--and hepatitis B virus DNA--positive chronic hepatitis BP Andreone, C Cursaro, A Gramenzi, et al.
Pageof 3